J CANCER RES CLIN 润色咨询

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

出版年份:1979 年文章数:3146 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=785, replyNumber=142, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2361118, encodeId=8908236111802, content=偏重的研究方向:肿瘤<br>经验分享:投资, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a2c5173408, createdName=146dfd1em22暂无昵称, createdTime=Fri Aug 28 07:12:19 CST 2026, time=2026-08-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2242975, encodeId=aa1422429e599, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”里的“Editor assigned ”状态,11天了,求问最近投稿的大佬进入下一步需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:54:44 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2282063, encodeId=77032282063e8, content=25.9.16投搞,25.9.17进入外审,25.9.20无理由拒稿。期间没有任何审稿人接受审稿直接被拒。外审就给2天的机会。无人接受审稿直接拒。离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b71d8589632, createdName=ms5000000083655939, createdTime=Sun Sep 21 08:51:08 CST 2025, time=2025-09-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2282722, encodeId=a0d12282e222f, content=被拒了😭<br>踩了三个致命坑:<br>主题匹配度,拒收纯基础研究。其次参考文献太随意,引用了3篇不相关文献,审稿人质疑学术严谨性。<br>最关键是数据合规性,未提前上传原始测序数据到公共库,也没完善知情同意说明,不符合期刊数据公开要求。<br>投稿的大家可避雷一下,不要像我一样白白耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Fri Sep 26 00:00:43 CST 2025, time=2025-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259002, encodeId=e77c22590026b, content=为什么修回块两个月了没有任何变化。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Thu Apr 03 17:29:43 CST 2025, time=2025-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2242973, encodeId=c57c22429e310, content=12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”状态里的“Editor assigned”,11天了,求问最近投稿的大佬,进入下一步送审需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:46:02 CST 2024, time=2024-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266879, encodeId=3c0122668e980, content=投稿20多天了,第二天通过技术审核,之后一直with editor,要发邮件问问吗,我看官网上第一次决定时间不是2天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98f9226796, createdName=ms9000002110376532, createdTime=Tue May 27 14:01:05 CST 2025, time=2025-05-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:外科;综述<br>经验分享:4.13投稿,5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2151188, encodeId=6f3b215118896, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:Part 1 审稿流程 Part 2 论坛常见问题 审稿流程如下: 2023-06-20 投稿 2023-06-20 技术检查通过,安排审稿人 2023-06-23 第一个审稿人接受审稿 2023-06-25 第二个审稿人接受审稿 2023-07-01 第一个审稿意见已回 2023-07-07 第二个审稿意见已回 2023-07-09 编辑汇总意见建议小修 2023-07-13 提交返修 2023-07-25 接受 后续包括编辑初步校对,选择OA还是非OA,最后校对都是在2、3天内完成,效率很高 常见问题 1、文章参考格式:Endnote APA 6th(稍微参考一下既往杂志文章都不会问出这问题) 2、投稿状态的顺序:Under review(稿件进入投稿流程)→Reviewer Accepted(有审稿人开始审你的稿件了)→Reviews report received(编辑收到了审稿人的意见)→Reviewer reports received/ Ready for editor' s decision(所有的审稿人意见都回来之后,才会开始进入编辑审查阶段,等待编辑汇总意见之后会发给你对文章的处理决定) 3、回顾性研究,case report,基础,生信,meta都收录,被秒拒的大多是优先级不够或者没有任何亮点,纯生信不加试验没有亮点凭啥接收呢?杂志审稿人态度还是很端正的,结合审稿意见来看对文章的大方向和细节都是有要求的,没有给人不专业和水分较深的感觉 4、不建议文章在未发布前共享到Research Square平台上,在投稿时把那个选项X掉比较好 5、杂志可以共同通讯,在文章中标注清楚即可 6、在进入审稿流程后,所有的文章动态更新都只有通讯作者邮箱才能收到,第一作者如需及时了解动态建议勤登网站查看进程 7、OA和非OA在后续文章处理上没有任何区别,OA文章在增加引用量上有其固有优势,掏钱发文章这种事见仁见智,btw这个杂志APC偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=508, replyNumber=37, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0b56493364, createdName=ms1000001633014790, createdTime=Thu Aug 03 23:00:50 CST 2023, time=2023-08-03, status=1, ipAttribution=陕西省)]
    2020-06-12 ms5502585941462392

    9月28投稿,10月7日直接接收,还以为是拒稿。😀

    142

    展开142条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=785, replyNumber=142, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2361118, encodeId=8908236111802, content=偏重的研究方向:肿瘤<br>经验分享:投资, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a2c5173408, createdName=146dfd1em22暂无昵称, createdTime=Fri Aug 28 07:12:19 CST 2026, time=2026-08-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2242975, encodeId=aa1422429e599, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”里的“Editor assigned ”状态,11天了,求问最近投稿的大佬进入下一步需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:54:44 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2282063, encodeId=77032282063e8, content=25.9.16投搞,25.9.17进入外审,25.9.20无理由拒稿。期间没有任何审稿人接受审稿直接被拒。外审就给2天的机会。无人接受审稿直接拒。离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b71d8589632, createdName=ms5000000083655939, createdTime=Sun Sep 21 08:51:08 CST 2025, time=2025-09-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2282722, encodeId=a0d12282e222f, content=被拒了😭<br>踩了三个致命坑:<br>主题匹配度,拒收纯基础研究。其次参考文献太随意,引用了3篇不相关文献,审稿人质疑学术严谨性。<br>最关键是数据合规性,未提前上传原始测序数据到公共库,也没完善知情同意说明,不符合期刊数据公开要求。<br>投稿的大家可避雷一下,不要像我一样白白耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Fri Sep 26 00:00:43 CST 2025, time=2025-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259002, encodeId=e77c22590026b, content=为什么修回块两个月了没有任何变化。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Thu Apr 03 17:29:43 CST 2025, time=2025-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2242973, encodeId=c57c22429e310, content=12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”状态里的“Editor assigned”,11天了,求问最近投稿的大佬,进入下一步送审需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:46:02 CST 2024, time=2024-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266879, encodeId=3c0122668e980, content=投稿20多天了,第二天通过技术审核,之后一直with editor,要发邮件问问吗,我看官网上第一次决定时间不是2天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98f9226796, createdName=ms9000002110376532, createdTime=Tue May 27 14:01:05 CST 2025, time=2025-05-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:外科;综述<br>经验分享:4.13投稿,5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2151188, encodeId=6f3b215118896, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:Part 1 审稿流程 Part 2 论坛常见问题 审稿流程如下: 2023-06-20 投稿 2023-06-20 技术检查通过,安排审稿人 2023-06-23 第一个审稿人接受审稿 2023-06-25 第二个审稿人接受审稿 2023-07-01 第一个审稿意见已回 2023-07-07 第二个审稿意见已回 2023-07-09 编辑汇总意见建议小修 2023-07-13 提交返修 2023-07-25 接受 后续包括编辑初步校对,选择OA还是非OA,最后校对都是在2、3天内完成,效率很高 常见问题 1、文章参考格式:Endnote APA 6th(稍微参考一下既往杂志文章都不会问出这问题) 2、投稿状态的顺序:Under review(稿件进入投稿流程)→Reviewer Accepted(有审稿人开始审你的稿件了)→Reviews report received(编辑收到了审稿人的意见)→Reviewer reports received/ Ready for editor' s decision(所有的审稿人意见都回来之后,才会开始进入编辑审查阶段,等待编辑汇总意见之后会发给你对文章的处理决定) 3、回顾性研究,case report,基础,生信,meta都收录,被秒拒的大多是优先级不够或者没有任何亮点,纯生信不加试验没有亮点凭啥接收呢?杂志审稿人态度还是很端正的,结合审稿意见来看对文章的大方向和细节都是有要求的,没有给人不专业和水分较深的感觉 4、不建议文章在未发布前共享到Research Square平台上,在投稿时把那个选项X掉比较好 5、杂志可以共同通讯,在文章中标注清楚即可 6、在进入审稿流程后,所有的文章动态更新都只有通讯作者邮箱才能收到,第一作者如需及时了解动态建议勤登网站查看进程 7、OA和非OA在后续文章处理上没有任何区别,OA文章在增加引用量上有其固有优势,掏钱发文章这种事见仁见智,btw这个杂志APC偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=508, replyNumber=37, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0b56493364, createdName=ms1000001633014790, createdTime=Thu Aug 03 23:00:50 CST 2023, time=2023-08-03, status=1, ipAttribution=陕西省)]
    2026-08-28 146dfd1em22暂无昵称 来自北京

    偏重的研究方向:肿瘤
    经验分享:投资

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=785, replyNumber=142, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2361118, encodeId=8908236111802, content=偏重的研究方向:肿瘤<br>经验分享:投资, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a2c5173408, createdName=146dfd1em22暂无昵称, createdTime=Fri Aug 28 07:12:19 CST 2026, time=2026-08-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2242975, encodeId=aa1422429e599, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”里的“Editor assigned ”状态,11天了,求问最近投稿的大佬进入下一步需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:54:44 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2282063, encodeId=77032282063e8, content=25.9.16投搞,25.9.17进入外审,25.9.20无理由拒稿。期间没有任何审稿人接受审稿直接被拒。外审就给2天的机会。无人接受审稿直接拒。离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b71d8589632, createdName=ms5000000083655939, createdTime=Sun Sep 21 08:51:08 CST 2025, time=2025-09-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2282722, encodeId=a0d12282e222f, content=被拒了😭<br>踩了三个致命坑:<br>主题匹配度,拒收纯基础研究。其次参考文献太随意,引用了3篇不相关文献,审稿人质疑学术严谨性。<br>最关键是数据合规性,未提前上传原始测序数据到公共库,也没完善知情同意说明,不符合期刊数据公开要求。<br>投稿的大家可避雷一下,不要像我一样白白耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Fri Sep 26 00:00:43 CST 2025, time=2025-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259002, encodeId=e77c22590026b, content=为什么修回块两个月了没有任何变化。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Thu Apr 03 17:29:43 CST 2025, time=2025-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2242973, encodeId=c57c22429e310, content=12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”状态里的“Editor assigned”,11天了,求问最近投稿的大佬,进入下一步送审需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:46:02 CST 2024, time=2024-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266879, encodeId=3c0122668e980, content=投稿20多天了,第二天通过技术审核,之后一直with editor,要发邮件问问吗,我看官网上第一次决定时间不是2天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98f9226796, createdName=ms9000002110376532, createdTime=Tue May 27 14:01:05 CST 2025, time=2025-05-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:外科;综述<br>经验分享:4.13投稿,5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2151188, encodeId=6f3b215118896, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:Part 1 审稿流程 Part 2 论坛常见问题 审稿流程如下: 2023-06-20 投稿 2023-06-20 技术检查通过,安排审稿人 2023-06-23 第一个审稿人接受审稿 2023-06-25 第二个审稿人接受审稿 2023-07-01 第一个审稿意见已回 2023-07-07 第二个审稿意见已回 2023-07-09 编辑汇总意见建议小修 2023-07-13 提交返修 2023-07-25 接受 后续包括编辑初步校对,选择OA还是非OA,最后校对都是在2、3天内完成,效率很高 常见问题 1、文章参考格式:Endnote APA 6th(稍微参考一下既往杂志文章都不会问出这问题) 2、投稿状态的顺序:Under review(稿件进入投稿流程)→Reviewer Accepted(有审稿人开始审你的稿件了)→Reviews report received(编辑收到了审稿人的意见)→Reviewer reports received/ Ready for editor' s decision(所有的审稿人意见都回来之后,才会开始进入编辑审查阶段,等待编辑汇总意见之后会发给你对文章的处理决定) 3、回顾性研究,case report,基础,生信,meta都收录,被秒拒的大多是优先级不够或者没有任何亮点,纯生信不加试验没有亮点凭啥接收呢?杂志审稿人态度还是很端正的,结合审稿意见来看对文章的大方向和细节都是有要求的,没有给人不专业和水分较深的感觉 4、不建议文章在未发布前共享到Research Square平台上,在投稿时把那个选项X掉比较好 5、杂志可以共同通讯,在文章中标注清楚即可 6、在进入审稿流程后,所有的文章动态更新都只有通讯作者邮箱才能收到,第一作者如需及时了解动态建议勤登网站查看进程 7、OA和非OA在后续文章处理上没有任何区别,OA文章在增加引用量上有其固有优势,掏钱发文章这种事见仁见智,btw这个杂志APC偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=508, replyNumber=37, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0b56493364, createdName=ms1000001633014790, createdTime=Thu Aug 03 23:00:50 CST 2023, time=2023-08-03, status=1, ipAttribution=陕西省)]
    2024-12-16 ms1000000866284071

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:临床
    经验分享:12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”里的“Editor assigned ”状态,11天了,求问最近投稿的大佬进入下一步需要多长时间?

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=785, replyNumber=142, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2361118, encodeId=8908236111802, content=偏重的研究方向:肿瘤<br>经验分享:投资, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a2c5173408, createdName=146dfd1em22暂无昵称, createdTime=Fri Aug 28 07:12:19 CST 2026, time=2026-08-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2242975, encodeId=aa1422429e599, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”里的“Editor assigned ”状态,11天了,求问最近投稿的大佬进入下一步需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:54:44 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2282063, encodeId=77032282063e8, content=25.9.16投搞,25.9.17进入外审,25.9.20无理由拒稿。期间没有任何审稿人接受审稿直接被拒。外审就给2天的机会。无人接受审稿直接拒。离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b71d8589632, createdName=ms5000000083655939, createdTime=Sun Sep 21 08:51:08 CST 2025, time=2025-09-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2282722, encodeId=a0d12282e222f, content=被拒了😭<br>踩了三个致命坑:<br>主题匹配度,拒收纯基础研究。其次参考文献太随意,引用了3篇不相关文献,审稿人质疑学术严谨性。<br>最关键是数据合规性,未提前上传原始测序数据到公共库,也没完善知情同意说明,不符合期刊数据公开要求。<br>投稿的大家可避雷一下,不要像我一样白白耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Fri Sep 26 00:00:43 CST 2025, time=2025-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259002, encodeId=e77c22590026b, content=为什么修回块两个月了没有任何变化。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Thu Apr 03 17:29:43 CST 2025, time=2025-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2242973, encodeId=c57c22429e310, content=12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”状态里的“Editor assigned”,11天了,求问最近投稿的大佬,进入下一步送审需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:46:02 CST 2024, time=2024-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266879, encodeId=3c0122668e980, content=投稿20多天了,第二天通过技术审核,之后一直with editor,要发邮件问问吗,我看官网上第一次决定时间不是2天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98f9226796, createdName=ms9000002110376532, createdTime=Tue May 27 14:01:05 CST 2025, time=2025-05-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:外科;综述<br>经验分享:4.13投稿,5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2151188, encodeId=6f3b215118896, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:Part 1 审稿流程 Part 2 论坛常见问题 审稿流程如下: 2023-06-20 投稿 2023-06-20 技术检查通过,安排审稿人 2023-06-23 第一个审稿人接受审稿 2023-06-25 第二个审稿人接受审稿 2023-07-01 第一个审稿意见已回 2023-07-07 第二个审稿意见已回 2023-07-09 编辑汇总意见建议小修 2023-07-13 提交返修 2023-07-25 接受 后续包括编辑初步校对,选择OA还是非OA,最后校对都是在2、3天内完成,效率很高 常见问题 1、文章参考格式:Endnote APA 6th(稍微参考一下既往杂志文章都不会问出这问题) 2、投稿状态的顺序:Under review(稿件进入投稿流程)→Reviewer Accepted(有审稿人开始审你的稿件了)→Reviews report received(编辑收到了审稿人的意见)→Reviewer reports received/ Ready for editor' s decision(所有的审稿人意见都回来之后,才会开始进入编辑审查阶段,等待编辑汇总意见之后会发给你对文章的处理决定) 3、回顾性研究,case report,基础,生信,meta都收录,被秒拒的大多是优先级不够或者没有任何亮点,纯生信不加试验没有亮点凭啥接收呢?杂志审稿人态度还是很端正的,结合审稿意见来看对文章的大方向和细节都是有要求的,没有给人不专业和水分较深的感觉 4、不建议文章在未发布前共享到Research Square平台上,在投稿时把那个选项X掉比较好 5、杂志可以共同通讯,在文章中标注清楚即可 6、在进入审稿流程后,所有的文章动态更新都只有通讯作者邮箱才能收到,第一作者如需及时了解动态建议勤登网站查看进程 7、OA和非OA在后续文章处理上没有任何区别,OA文章在增加引用量上有其固有优势,掏钱发文章这种事见仁见智,btw这个杂志APC偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=508, replyNumber=37, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0b56493364, createdName=ms1000001633014790, createdTime=Thu Aug 03 23:00:50 CST 2023, time=2023-08-03, status=1, ipAttribution=陕西省)]
    2025-09-21 ms5000000083655939 来自江苏省

    25.9.16投搞,25.9.17进入外审,25.9.20无理由拒稿。期间没有任何审稿人接受审稿直接被拒。外审就给2天的机会。无人接受审稿直接拒。离谱

    5

    展开5条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=785, replyNumber=142, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2361118, encodeId=8908236111802, content=偏重的研究方向:肿瘤<br>经验分享:投资, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a2c5173408, createdName=146dfd1em22暂无昵称, createdTime=Fri Aug 28 07:12:19 CST 2026, time=2026-08-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2242975, encodeId=aa1422429e599, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”里的“Editor assigned ”状态,11天了,求问最近投稿的大佬进入下一步需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:54:44 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2282063, encodeId=77032282063e8, content=25.9.16投搞,25.9.17进入外审,25.9.20无理由拒稿。期间没有任何审稿人接受审稿直接被拒。外审就给2天的机会。无人接受审稿直接拒。离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b71d8589632, createdName=ms5000000083655939, createdTime=Sun Sep 21 08:51:08 CST 2025, time=2025-09-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2282722, encodeId=a0d12282e222f, content=被拒了😭<br>踩了三个致命坑:<br>主题匹配度,拒收纯基础研究。其次参考文献太随意,引用了3篇不相关文献,审稿人质疑学术严谨性。<br>最关键是数据合规性,未提前上传原始测序数据到公共库,也没完善知情同意说明,不符合期刊数据公开要求。<br>投稿的大家可避雷一下,不要像我一样白白耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Fri Sep 26 00:00:43 CST 2025, time=2025-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259002, encodeId=e77c22590026b, content=为什么修回块两个月了没有任何变化。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Thu Apr 03 17:29:43 CST 2025, time=2025-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2242973, encodeId=c57c22429e310, content=12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”状态里的“Editor assigned”,11天了,求问最近投稿的大佬,进入下一步送审需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:46:02 CST 2024, time=2024-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266879, encodeId=3c0122668e980, content=投稿20多天了,第二天通过技术审核,之后一直with editor,要发邮件问问吗,我看官网上第一次决定时间不是2天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98f9226796, createdName=ms9000002110376532, createdTime=Tue May 27 14:01:05 CST 2025, time=2025-05-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:外科;综述<br>经验分享:4.13投稿,5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2151188, encodeId=6f3b215118896, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:Part 1 审稿流程 Part 2 论坛常见问题 审稿流程如下: 2023-06-20 投稿 2023-06-20 技术检查通过,安排审稿人 2023-06-23 第一个审稿人接受审稿 2023-06-25 第二个审稿人接受审稿 2023-07-01 第一个审稿意见已回 2023-07-07 第二个审稿意见已回 2023-07-09 编辑汇总意见建议小修 2023-07-13 提交返修 2023-07-25 接受 后续包括编辑初步校对,选择OA还是非OA,最后校对都是在2、3天内完成,效率很高 常见问题 1、文章参考格式:Endnote APA 6th(稍微参考一下既往杂志文章都不会问出这问题) 2、投稿状态的顺序:Under review(稿件进入投稿流程)→Reviewer Accepted(有审稿人开始审你的稿件了)→Reviews report received(编辑收到了审稿人的意见)→Reviewer reports received/ Ready for editor' s decision(所有的审稿人意见都回来之后,才会开始进入编辑审查阶段,等待编辑汇总意见之后会发给你对文章的处理决定) 3、回顾性研究,case report,基础,生信,meta都收录,被秒拒的大多是优先级不够或者没有任何亮点,纯生信不加试验没有亮点凭啥接收呢?杂志审稿人态度还是很端正的,结合审稿意见来看对文章的大方向和细节都是有要求的,没有给人不专业和水分较深的感觉 4、不建议文章在未发布前共享到Research Square平台上,在投稿时把那个选项X掉比较好 5、杂志可以共同通讯,在文章中标注清楚即可 6、在进入审稿流程后,所有的文章动态更新都只有通讯作者邮箱才能收到,第一作者如需及时了解动态建议勤登网站查看进程 7、OA和非OA在后续文章处理上没有任何区别,OA文章在增加引用量上有其固有优势,掏钱发文章这种事见仁见智,btw这个杂志APC偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=508, replyNumber=37, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0b56493364, createdName=ms1000001633014790, createdTime=Thu Aug 03 23:00:50 CST 2023, time=2023-08-03, status=1, ipAttribution=陕西省)]
    2025-09-26 ms8000002977722174 来自上海

    被拒了😭
    踩了三个致命坑:
    主题匹配度,拒收纯基础研究。其次参考文献太随意,引用了3篇不相关文献,审稿人质疑学术严谨性。
    最关键是数据合规性,未提前上传原始测序数据到公共库,也没完善知情同意说明,不符合期刊数据公开要求。
    投稿的大家可避雷一下,不要像我一样白白耽误时间。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=785, replyNumber=142, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2361118, encodeId=8908236111802, content=偏重的研究方向:肿瘤<br>经验分享:投资, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a2c5173408, createdName=146dfd1em22暂无昵称, createdTime=Fri Aug 28 07:12:19 CST 2026, time=2026-08-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2242975, encodeId=aa1422429e599, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”里的“Editor assigned ”状态,11天了,求问最近投稿的大佬进入下一步需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:54:44 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2282063, encodeId=77032282063e8, content=25.9.16投搞,25.9.17进入外审,25.9.20无理由拒稿。期间没有任何审稿人接受审稿直接被拒。外审就给2天的机会。无人接受审稿直接拒。离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b71d8589632, createdName=ms5000000083655939, createdTime=Sun Sep 21 08:51:08 CST 2025, time=2025-09-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2282722, encodeId=a0d12282e222f, content=被拒了😭<br>踩了三个致命坑:<br>主题匹配度,拒收纯基础研究。其次参考文献太随意,引用了3篇不相关文献,审稿人质疑学术严谨性。<br>最关键是数据合规性,未提前上传原始测序数据到公共库,也没完善知情同意说明,不符合期刊数据公开要求。<br>投稿的大家可避雷一下,不要像我一样白白耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Fri Sep 26 00:00:43 CST 2025, time=2025-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259002, encodeId=e77c22590026b, content=为什么修回块两个月了没有任何变化。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Thu Apr 03 17:29:43 CST 2025, time=2025-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2242973, encodeId=c57c22429e310, content=12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”状态里的“Editor assigned”,11天了,求问最近投稿的大佬,进入下一步送审需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:46:02 CST 2024, time=2024-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266879, encodeId=3c0122668e980, content=投稿20多天了,第二天通过技术审核,之后一直with editor,要发邮件问问吗,我看官网上第一次决定时间不是2天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98f9226796, createdName=ms9000002110376532, createdTime=Tue May 27 14:01:05 CST 2025, time=2025-05-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:外科;综述<br>经验分享:4.13投稿,5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2151188, encodeId=6f3b215118896, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:Part 1 审稿流程 Part 2 论坛常见问题 审稿流程如下: 2023-06-20 投稿 2023-06-20 技术检查通过,安排审稿人 2023-06-23 第一个审稿人接受审稿 2023-06-25 第二个审稿人接受审稿 2023-07-01 第一个审稿意见已回 2023-07-07 第二个审稿意见已回 2023-07-09 编辑汇总意见建议小修 2023-07-13 提交返修 2023-07-25 接受 后续包括编辑初步校对,选择OA还是非OA,最后校对都是在2、3天内完成,效率很高 常见问题 1、文章参考格式:Endnote APA 6th(稍微参考一下既往杂志文章都不会问出这问题) 2、投稿状态的顺序:Under review(稿件进入投稿流程)→Reviewer Accepted(有审稿人开始审你的稿件了)→Reviews report received(编辑收到了审稿人的意见)→Reviewer reports received/ Ready for editor' s decision(所有的审稿人意见都回来之后,才会开始进入编辑审查阶段,等待编辑汇总意见之后会发给你对文章的处理决定) 3、回顾性研究,case report,基础,生信,meta都收录,被秒拒的大多是优先级不够或者没有任何亮点,纯生信不加试验没有亮点凭啥接收呢?杂志审稿人态度还是很端正的,结合审稿意见来看对文章的大方向和细节都是有要求的,没有给人不专业和水分较深的感觉 4、不建议文章在未发布前共享到Research Square平台上,在投稿时把那个选项X掉比较好 5、杂志可以共同通讯,在文章中标注清楚即可 6、在进入审稿流程后,所有的文章动态更新都只有通讯作者邮箱才能收到,第一作者如需及时了解动态建议勤登网站查看进程 7、OA和非OA在后续文章处理上没有任何区别,OA文章在增加引用量上有其固有优势,掏钱发文章这种事见仁见智,btw这个杂志APC偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=508, replyNumber=37, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0b56493364, createdName=ms1000001633014790, createdTime=Thu Aug 03 23:00:50 CST 2023, time=2023-08-03, status=1, ipAttribution=陕西省)]
    2025-04-03 ms8000001608810099 来自山东省

    为什么修回块两个月了没有任何变化。。

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=785, replyNumber=142, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2361118, encodeId=8908236111802, content=偏重的研究方向:肿瘤<br>经验分享:投资, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a2c5173408, createdName=146dfd1em22暂无昵称, createdTime=Fri Aug 28 07:12:19 CST 2026, time=2026-08-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2242975, encodeId=aa1422429e599, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”里的“Editor assigned ”状态,11天了,求问最近投稿的大佬进入下一步需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:54:44 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2282063, encodeId=77032282063e8, content=25.9.16投搞,25.9.17进入外审,25.9.20无理由拒稿。期间没有任何审稿人接受审稿直接被拒。外审就给2天的机会。无人接受审稿直接拒。离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b71d8589632, createdName=ms5000000083655939, createdTime=Sun Sep 21 08:51:08 CST 2025, time=2025-09-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2282722, encodeId=a0d12282e222f, content=被拒了😭<br>踩了三个致命坑:<br>主题匹配度,拒收纯基础研究。其次参考文献太随意,引用了3篇不相关文献,审稿人质疑学术严谨性。<br>最关键是数据合规性,未提前上传原始测序数据到公共库,也没完善知情同意说明,不符合期刊数据公开要求。<br>投稿的大家可避雷一下,不要像我一样白白耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Fri Sep 26 00:00:43 CST 2025, time=2025-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259002, encodeId=e77c22590026b, content=为什么修回块两个月了没有任何变化。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Thu Apr 03 17:29:43 CST 2025, time=2025-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2242973, encodeId=c57c22429e310, content=12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”状态里的“Editor assigned”,11天了,求问最近投稿的大佬,进入下一步送审需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:46:02 CST 2024, time=2024-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266879, encodeId=3c0122668e980, content=投稿20多天了,第二天通过技术审核,之后一直with editor,要发邮件问问吗,我看官网上第一次决定时间不是2天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98f9226796, createdName=ms9000002110376532, createdTime=Tue May 27 14:01:05 CST 2025, time=2025-05-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:外科;综述<br>经验分享:4.13投稿,5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2151188, encodeId=6f3b215118896, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:Part 1 审稿流程 Part 2 论坛常见问题 审稿流程如下: 2023-06-20 投稿 2023-06-20 技术检查通过,安排审稿人 2023-06-23 第一个审稿人接受审稿 2023-06-25 第二个审稿人接受审稿 2023-07-01 第一个审稿意见已回 2023-07-07 第二个审稿意见已回 2023-07-09 编辑汇总意见建议小修 2023-07-13 提交返修 2023-07-25 接受 后续包括编辑初步校对,选择OA还是非OA,最后校对都是在2、3天内完成,效率很高 常见问题 1、文章参考格式:Endnote APA 6th(稍微参考一下既往杂志文章都不会问出这问题) 2、投稿状态的顺序:Under review(稿件进入投稿流程)→Reviewer Accepted(有审稿人开始审你的稿件了)→Reviews report received(编辑收到了审稿人的意见)→Reviewer reports received/ Ready for editor' s decision(所有的审稿人意见都回来之后,才会开始进入编辑审查阶段,等待编辑汇总意见之后会发给你对文章的处理决定) 3、回顾性研究,case report,基础,生信,meta都收录,被秒拒的大多是优先级不够或者没有任何亮点,纯生信不加试验没有亮点凭啥接收呢?杂志审稿人态度还是很端正的,结合审稿意见来看对文章的大方向和细节都是有要求的,没有给人不专业和水分较深的感觉 4、不建议文章在未发布前共享到Research Square平台上,在投稿时把那个选项X掉比较好 5、杂志可以共同通讯,在文章中标注清楚即可 6、在进入审稿流程后,所有的文章动态更新都只有通讯作者邮箱才能收到,第一作者如需及时了解动态建议勤登网站查看进程 7、OA和非OA在后续文章处理上没有任何区别,OA文章在增加引用量上有其固有优势,掏钱发文章这种事见仁见智,btw这个杂志APC偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=508, replyNumber=37, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0b56493364, createdName=ms1000001633014790, createdTime=Thu Aug 03 23:00:50 CST 2023, time=2023-08-03, status=1, ipAttribution=陕西省)]
    2024-12-16 ms1000000866284071 来自山东省

    12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”状态里的“Editor assigned”,11天了,求问最近投稿的大佬,进入下一步送审需要多长时间?

    3

    展开3条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=785, replyNumber=142, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2361118, encodeId=8908236111802, content=偏重的研究方向:肿瘤<br>经验分享:投资, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a2c5173408, createdName=146dfd1em22暂无昵称, createdTime=Fri Aug 28 07:12:19 CST 2026, time=2026-08-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2242975, encodeId=aa1422429e599, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”里的“Editor assigned ”状态,11天了,求问最近投稿的大佬进入下一步需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:54:44 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2282063, encodeId=77032282063e8, content=25.9.16投搞,25.9.17进入外审,25.9.20无理由拒稿。期间没有任何审稿人接受审稿直接被拒。外审就给2天的机会。无人接受审稿直接拒。离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b71d8589632, createdName=ms5000000083655939, createdTime=Sun Sep 21 08:51:08 CST 2025, time=2025-09-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2282722, encodeId=a0d12282e222f, content=被拒了😭<br>踩了三个致命坑:<br>主题匹配度,拒收纯基础研究。其次参考文献太随意,引用了3篇不相关文献,审稿人质疑学术严谨性。<br>最关键是数据合规性,未提前上传原始测序数据到公共库,也没完善知情同意说明,不符合期刊数据公开要求。<br>投稿的大家可避雷一下,不要像我一样白白耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Fri Sep 26 00:00:43 CST 2025, time=2025-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259002, encodeId=e77c22590026b, content=为什么修回块两个月了没有任何变化。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Thu Apr 03 17:29:43 CST 2025, time=2025-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2242973, encodeId=c57c22429e310, content=12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”状态里的“Editor assigned”,11天了,求问最近投稿的大佬,进入下一步送审需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:46:02 CST 2024, time=2024-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266879, encodeId=3c0122668e980, content=投稿20多天了,第二天通过技术审核,之后一直with editor,要发邮件问问吗,我看官网上第一次决定时间不是2天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98f9226796, createdName=ms9000002110376532, createdTime=Tue May 27 14:01:05 CST 2025, time=2025-05-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:外科;综述<br>经验分享:4.13投稿,5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2151188, encodeId=6f3b215118896, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:Part 1 审稿流程 Part 2 论坛常见问题 审稿流程如下: 2023-06-20 投稿 2023-06-20 技术检查通过,安排审稿人 2023-06-23 第一个审稿人接受审稿 2023-06-25 第二个审稿人接受审稿 2023-07-01 第一个审稿意见已回 2023-07-07 第二个审稿意见已回 2023-07-09 编辑汇总意见建议小修 2023-07-13 提交返修 2023-07-25 接受 后续包括编辑初步校对,选择OA还是非OA,最后校对都是在2、3天内完成,效率很高 常见问题 1、文章参考格式:Endnote APA 6th(稍微参考一下既往杂志文章都不会问出这问题) 2、投稿状态的顺序:Under review(稿件进入投稿流程)→Reviewer Accepted(有审稿人开始审你的稿件了)→Reviews report received(编辑收到了审稿人的意见)→Reviewer reports received/ Ready for editor' s decision(所有的审稿人意见都回来之后,才会开始进入编辑审查阶段,等待编辑汇总意见之后会发给你对文章的处理决定) 3、回顾性研究,case report,基础,生信,meta都收录,被秒拒的大多是优先级不够或者没有任何亮点,纯生信不加试验没有亮点凭啥接收呢?杂志审稿人态度还是很端正的,结合审稿意见来看对文章的大方向和细节都是有要求的,没有给人不专业和水分较深的感觉 4、不建议文章在未发布前共享到Research Square平台上,在投稿时把那个选项X掉比较好 5、杂志可以共同通讯,在文章中标注清楚即可 6、在进入审稿流程后,所有的文章动态更新都只有通讯作者邮箱才能收到,第一作者如需及时了解动态建议勤登网站查看进程 7、OA和非OA在后续文章处理上没有任何区别,OA文章在增加引用量上有其固有优势,掏钱发文章这种事见仁见智,btw这个杂志APC偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=508, replyNumber=37, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0b56493364, createdName=ms1000001633014790, createdTime=Thu Aug 03 23:00:50 CST 2023, time=2023-08-03, status=1, ipAttribution=陕西省)]
    2025-05-27 ms9000002110376532 来自山东省

    投稿20多天了,第二天通过技术审核,之后一直with editor,要发邮件问问吗,我看官网上第一次决定时间不是2天吗

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=785, replyNumber=142, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2361118, encodeId=8908236111802, content=偏重的研究方向:肿瘤<br>经验分享:投资, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a2c5173408, createdName=146dfd1em22暂无昵称, createdTime=Fri Aug 28 07:12:19 CST 2026, time=2026-08-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2242975, encodeId=aa1422429e599, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”里的“Editor assigned ”状态,11天了,求问最近投稿的大佬进入下一步需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:54:44 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2282063, encodeId=77032282063e8, content=25.9.16投搞,25.9.17进入外审,25.9.20无理由拒稿。期间没有任何审稿人接受审稿直接被拒。外审就给2天的机会。无人接受审稿直接拒。离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b71d8589632, createdName=ms5000000083655939, createdTime=Sun Sep 21 08:51:08 CST 2025, time=2025-09-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2282722, encodeId=a0d12282e222f, content=被拒了😭<br>踩了三个致命坑:<br>主题匹配度,拒收纯基础研究。其次参考文献太随意,引用了3篇不相关文献,审稿人质疑学术严谨性。<br>最关键是数据合规性,未提前上传原始测序数据到公共库,也没完善知情同意说明,不符合期刊数据公开要求。<br>投稿的大家可避雷一下,不要像我一样白白耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Fri Sep 26 00:00:43 CST 2025, time=2025-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259002, encodeId=e77c22590026b, content=为什么修回块两个月了没有任何变化。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Thu Apr 03 17:29:43 CST 2025, time=2025-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2242973, encodeId=c57c22429e310, content=12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”状态里的“Editor assigned”,11天了,求问最近投稿的大佬,进入下一步送审需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:46:02 CST 2024, time=2024-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266879, encodeId=3c0122668e980, content=投稿20多天了,第二天通过技术审核,之后一直with editor,要发邮件问问吗,我看官网上第一次决定时间不是2天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98f9226796, createdName=ms9000002110376532, createdTime=Tue May 27 14:01:05 CST 2025, time=2025-05-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:外科;综述<br>经验分享:4.13投稿,5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2151188, encodeId=6f3b215118896, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:Part 1 审稿流程 Part 2 论坛常见问题 审稿流程如下: 2023-06-20 投稿 2023-06-20 技术检查通过,安排审稿人 2023-06-23 第一个审稿人接受审稿 2023-06-25 第二个审稿人接受审稿 2023-07-01 第一个审稿意见已回 2023-07-07 第二个审稿意见已回 2023-07-09 编辑汇总意见建议小修 2023-07-13 提交返修 2023-07-25 接受 后续包括编辑初步校对,选择OA还是非OA,最后校对都是在2、3天内完成,效率很高 常见问题 1、文章参考格式:Endnote APA 6th(稍微参考一下既往杂志文章都不会问出这问题) 2、投稿状态的顺序:Under review(稿件进入投稿流程)→Reviewer Accepted(有审稿人开始审你的稿件了)→Reviews report received(编辑收到了审稿人的意见)→Reviewer reports received/ Ready for editor' s decision(所有的审稿人意见都回来之后,才会开始进入编辑审查阶段,等待编辑汇总意见之后会发给你对文章的处理决定) 3、回顾性研究,case report,基础,生信,meta都收录,被秒拒的大多是优先级不够或者没有任何亮点,纯生信不加试验没有亮点凭啥接收呢?杂志审稿人态度还是很端正的,结合审稿意见来看对文章的大方向和细节都是有要求的,没有给人不专业和水分较深的感觉 4、不建议文章在未发布前共享到Research Square平台上,在投稿时把那个选项X掉比较好 5、杂志可以共同通讯,在文章中标注清楚即可 6、在进入审稿流程后,所有的文章动态更新都只有通讯作者邮箱才能收到,第一作者如需及时了解动态建议勤登网站查看进程 7、OA和非OA在后续文章处理上没有任何区别,OA文章在增加引用量上有其固有优势,掏钱发文章这种事见仁见智,btw这个杂志APC偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=508, replyNumber=37, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0b56493364, createdName=ms1000001633014790, createdTime=Thu Aug 03 23:00:50 CST 2023, time=2023-08-03, status=1, ipAttribution=陕西省)]
    2023-05-23 胸外科小大夫 来自辽宁省

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向:外科;综述
    经验分享:4.13投稿,5.23接收。一个月多一点直接接收。特别有效率。

    13

    展开13条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=602136, encodeId=8589602136d1, content=9月28投稿,10月7日直接接收,还以为是拒稿。😀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=785, replyNumber=142, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKVvMIdBzydxvTLf3L1GaeshlhhObuunGflfr3g7nIWDic7gMA3qJtibSju8JlxIfgk7ctQllMfqFBA/132, createdBy=edd72312792, createdName=ms5502585941462392, createdTime=Fri Jun 12 22:03:58 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2361118, encodeId=8908236111802, content=偏重的研究方向:肿瘤<br>经验分享:投资, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3a2c5173408, createdName=146dfd1em22暂无昵称, createdTime=Fri Aug 28 07:12:19 CST 2026, time=2026-08-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2242975, encodeId=aa1422429e599, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:临床<br>经验分享:12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”里的“Editor assigned ”状态,11天了,求问最近投稿的大佬进入下一步需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:54:44 CST 2024, time=2024-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2282063, encodeId=77032282063e8, content=25.9.16投搞,25.9.17进入外审,25.9.20无理由拒稿。期间没有任何审稿人接受审稿直接被拒。外审就给2天的机会。无人接受审稿直接拒。离谱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b71d8589632, createdName=ms5000000083655939, createdTime=Sun Sep 21 08:51:08 CST 2025, time=2025-09-21, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2282722, encodeId=a0d12282e222f, content=被拒了😭<br>踩了三个致命坑:<br>主题匹配度,拒收纯基础研究。其次参考文献太随意,引用了3篇不相关文献,审稿人质疑学术严谨性。<br>最关键是数据合规性,未提前上传原始测序数据到公共库,也没完善知情同意说明,不符合期刊数据公开要求。<br>投稿的大家可避雷一下,不要像我一样白白耽误时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms8000002977722174, createdTime=Fri Sep 26 00:00:43 CST 2025, time=2025-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2259002, encodeId=e77c22590026b, content=为什么修回块两个月了没有任何变化。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a42b8565171, createdName=ms8000001608810099, createdTime=Thu Apr 03 17:29:43 CST 2025, time=2025-04-03, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2242973, encodeId=c57c22429e310, content=12.5号投稿,第2天通过技术审核,现在一直停留在“with editor”状态里的“Editor assigned”,11天了,求问最近投稿的大佬,进入下一步送审需要多长时间?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=294a8447582, createdName=ms1000000866284071, createdTime=Mon Dec 16 19:46:02 CST 2024, time=2024-12-16, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2266879, encodeId=3c0122668e980, content=投稿20多天了,第二天通过技术审核,之后一直with editor,要发邮件问问吗,我看官网上第一次决定时间不是2天吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d98f9226796, createdName=ms9000002110376532, createdTime=Tue May 27 14:01:05 CST 2025, time=2025-05-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2138638, encodeId=c55d213863802, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:外科;综述<br>经验分享:4.13投稿,5.23接收。一个月多一点直接接收。特别有效率。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221102/369591c85731477baa49cc9e4607aa59/710024ddb86e4cc79b2f2a73449bbb88.jpg, createdBy=041e5339211, createdName=胸外科小大夫, createdTime=Tue May 23 20:02:59 CST 2023, time=2023-05-23, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2151188, encodeId=6f3b215118896, content=审稿速度:2.0 | 投稿命中率:75.0<br>偏重的研究方向:肿瘤<br>经验分享:Part 1 审稿流程 Part 2 论坛常见问题 审稿流程如下: 2023-06-20 投稿 2023-06-20 技术检查通过,安排审稿人 2023-06-23 第一个审稿人接受审稿 2023-06-25 第二个审稿人接受审稿 2023-07-01 第一个审稿意见已回 2023-07-07 第二个审稿意见已回 2023-07-09 编辑汇总意见建议小修 2023-07-13 提交返修 2023-07-25 接受 后续包括编辑初步校对,选择OA还是非OA,最后校对都是在2、3天内完成,效率很高 常见问题 1、文章参考格式:Endnote APA 6th(稍微参考一下既往杂志文章都不会问出这问题) 2、投稿状态的顺序:Under review(稿件进入投稿流程)→Reviewer Accepted(有审稿人开始审你的稿件了)→Reviews report received(编辑收到了审稿人的意见)→Reviewer reports received/ Ready for editor' s decision(所有的审稿人意见都回来之后,才会开始进入编辑审查阶段,等待编辑汇总意见之后会发给你对文章的处理决定) 3、回顾性研究,case report,基础,生信,meta都收录,被秒拒的大多是优先级不够或者没有任何亮点,纯生信不加试验没有亮点凭啥接收呢?杂志审稿人态度还是很端正的,结合审稿意见来看对文章的大方向和细节都是有要求的,没有给人不专业和水分较深的感觉 4、不建议文章在未发布前共享到Research Square平台上,在投稿时把那个选项X掉比较好 5、杂志可以共同通讯,在文章中标注清楚即可 6、在进入审稿流程后,所有的文章动态更新都只有通讯作者邮箱才能收到,第一作者如需及时了解动态建议勤登网站查看进程 7、OA和非OA在后续文章处理上没有任何区别,OA文章在增加引用量上有其固有优势,掏钱发文章这种事见仁见智,btw这个杂志APC偏贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=508, replyNumber=37, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f0b56493364, createdName=ms1000001633014790, createdTime=Thu Aug 03 23:00:50 CST 2023, time=2023-08-03, status=1, ipAttribution=陕西省)]
    2023-08-03 ms1000001633014790 来自陕西省

    审稿速度:2.0 | 投稿命中率:75.0
    偏重的研究方向:肿瘤
    经验分享:Part 1 审稿流程 Part 2 论坛常见问题 审稿流程如下: 2023-06-20 投稿 2023-06-20 技术检查通过,安排审稿人 2023-06-23 第一个审稿人接受审稿 2023-06-25 第二个审稿人接受审稿 2023-07-01 第一个审稿意见已回 2023-07-07 第二个审稿意见已回 2023-07-09 编辑汇总意见建议小修 2023-07-13 提交返修 2023-07-25 接受 后续包括编辑初步校对,选择OA还是非OA,最后校对都是在2、3天内完成,效率很高 常见问题 1、文章参考格式:Endnote APA 6th(稍微参考一下既往杂志文章都不会问出这问题) 2、投稿状态的顺序:Under review(稿件进入投稿流程)→Reviewer Accepted(有审稿人开始审你的稿件了)→Reviews report received(编辑收到了审稿人的意见)→Reviewer reports received/ Ready for editor' s decision(所有的审稿人意见都回来之后,才会开始进入编辑审查阶段,等待编辑汇总意见之后会发给你对文章的处理决定) 3、回顾性研究,case report,基础,生信,meta都收录,被秒拒的大多是优先级不够或者没有任何亮点,纯生信不加试验没有亮点凭啥接收呢?杂志审稿人态度还是很端正的,结合审稿意见来看对文章的大方向和细节都是有要求的,没有给人不专业和水分较深的感觉 4、不建议文章在未发布前共享到Research Square平台上,在投稿时把那个选项X掉比较好 5、杂志可以共同通讯,在文章中标注清楚即可 6、在进入审稿流程后,所有的文章动态更新都只有通讯作者邮箱才能收到,第一作者如需及时了解动态建议勤登网站查看进程 7、OA和非OA在后续文章处理上没有任何区别,OA文章在增加引用量上有其固有优势,掏钱发文章这种事见仁见智,btw这个杂志APC偏贵

    37

    展开37条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分